Variables | Recurrence | Survival | ||
---|---|---|---|---|
HR (95% CI) | Pvalue | HR (95% CI) | Pvalue | |
Univariate analysis | ||||
Sex | ||||
Male/female | 0.813 (0.479-1.518) | 0.604 | 0.829 (0.424-1.618) | 0.662 |
Age (yr) | ||||
≤ 60/> 60 | 1.506 (0.804-2.712) | 0.163 | 1.822 (0.947-3.528) | 0.065 |
Tumor size (cm) | ||||
≤ 5/> 5 | 0.876 (0.163-0.665) | 0.687 | 0.880 (0.438-1.723) | 0.704 |
Tumor location | ||||
Colon/rectum | 0.812 (0.445-1.423) | 0.518 | 0.904 (0.476-1.734) | 0.778 |
Tumor differentiation | ||||
I-II/III-IV | 1.212 (0.654-2.308) | 0.501 | 1.151 (0.576-2.358) | 0.650 |
Tumor status | ||||
T1-2/T3-4 | 0.866 (0.475-1.618) | 0.687 | 1.020 (0.504-2.028) | 0.904 |
Lymph node metastasis | ||||
N0/N1-2 | 2.707 (1.502-4.912) | 0.011 | 2.812 (1.413-5.509) | 0.012 |
TNM stage | ||||
I-II/III-IV | 3.554 (1.932-6.526) | <0.001 | 3.385 (1.677-6.843) | <0.001 |
ERCC1 expression | ||||
Negative/positive | 3.556 (1.919-6.932) | <0.001 | 4.038 (1.913-8.712) | <0.001 |
BRCA1 expression | ||||
Negative/positive | 3.244 (1.191-7.012) | <0.001 | 4.033 (1.906-8.512) | <0.001 |
Multivariate analysis | ||||
LNM | ||||
N0/N1-2 | 0.210 (0.051-0.758) | 0.018 | 0.196 (0.041-0.852) | 0.028 |
TNM stage | ||||
I-II/III-IV | 8.905 (2.072-38.190) | 0.003 | 9.037 (1.703-48.105) | 0.010 |
ERCC1 expression | ||||
Negative/positive | 2.673 (1.134-6.011) | 0.018 | 3.011 (1.236-7.95) | 0.031 |
BRCA1 expression | ||||
Negative/positive | 2.401 (1.115-5.722) | 0.013 | 2.844 (1.106-7.44) | 0.021 |